Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
about
Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerAkt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells.Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells.Optimization of an anti-HER2 nanobody expression using the Taguchi method.
P2860
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@ast
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@en
type
label
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@ast
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@en
prefLabel
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@ast
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@en
P2860
P1476
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.
@en
P2093
Joseph Wahler
Nanjoo Suh
P2860
P2888
P304
P356
10.1007/S40495-015-0040-Z
P577
2015-04-19T00:00:00Z